Restorative neurosurgery: Opportunities for restoration of function in acquired, degenerative, and idiopathic neurological diseases

Neurosurgery

Volumn 45, Issue 4, 1999, Pages 741-752

  Thompson, Todd P ^a   Lunsford, L Dade ^a   Kondziolka, Douglas ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cell transplantation; Central nervous system; Functional neurosurgery; Gene therapy; Immunosuppression; Neurotrophic factors; Restorative neurosurgery; Stereotactic surgery

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; NEUROTROPHIC FACTOR;

BRAIN ISCHEMIA; CELL TRANSPLANTATION; CONTINUING EDUCATION; DEGENERATIVE DISEASE; DISEASE MODEL; FUNCTIONAL ASSESSMENT; GENE TARGETING; GENE THERAPY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; NERVE REGENERATION; NERVOUS SYSTEM FUNCTION; NEUROLOGIC DISEASE; NEUROSCIENCE; NEUROSURGERY; PRIORITY JOURNAL; REMYELINIZATION; REVIEW; TREATMENT OUTCOME;

ANIMALS; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM DISEASES; DISEASE MODELS, ANIMAL; FORECASTING; GENE THERAPY; HUMANS; IMMUNOSUPPRESSION; MICROSURGERY; NERVE GROWTH FACTORS; NEURODEGENERATIVE DISEASES; STEREOTAXIC TECHNIQUES;

EID: 0032834891     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199910000-00001     Document Type: Review

References (118)

1. Adams RD, Victor M, Ropper A: Cerebrovascular diseases, in Wonsiewicz M (ed): Principles of Neurology. New York, McGrawHill, 1997, ed 6, pp 777-873.
2. Adams RD, Victor M, Ropper A: Degenerative diseases of the nervous system, in Wonsiewicz M (ed): Principles of Neurology. New York, McGraw-Hill, 1997, ed 6, pp 1046-1107.
3. Ahlskog J: Parkinson's disease: New treatment strategies. Compr Ther 16:41-46, 1990.
4. Ahlskog J: Cerebral transplantation for Parkinson's disease: Current progress and future prospects. Mayo Clin Froc 68:578-591, 1993.
5. Aihara N, Mizukawa K, Koide K, Mabe H, Nishino H: Striatal grafts in infarct striatopallidum increase GABA release, reorganize GABAA receptor and improve water-maze learning in the rat. Brain Res Bull 33:483-488, 1994.
6. Andrews PW, Damjanov I, Simon D, Banting G, Carlin C, Dracopoli N, Fogh J: Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Lab Invest 50:147-162, 1984.
7. Ansari AA, Mayne A, Freed C, Breeze R, Schneck S, O'Brien C, Kriek E, Zhang Y, Mazziotta J, Hutchinson M, Schroter G, Bakay RA, Boyer K, Sundstrom JB: Lack of a detectable systemic humoral/cellular allogeneic response in human and nonhuman primate recipients of embryonic mesencephalic allografts for the therapy of Parkinson's disease. Transplant Proc 27:1401-1405, 1995.
8. Aoki H, Onodera H, Yae T, Jian Z, Kogure K: Neural grafting to ischémie CA1 lesions in the rat hippocampus: An autoradiographie study. Neuroscience 56:345-354, 1993.
9. Backlund EO, Granberg PO, Hamberger B, Gedvall G, Seiger A, Olsen L: Transplantation of adrenal medullary tissue to striatum in Parkinsonism: First clinical trials. J Neurosurg 62:169-173, 1985.
10. Bakay RAE, Boyer A: The future of central nervous system tissue transplantation, in Gildenberg PL, Tasker RR, Franklin OP (eds): Textbook of Stcreotactic mid Functional Neurositrgery. New York, McGraw-Hill, 1998, pp 2091-2101.
11. Bennett DA, Beckett L, Murray A, Shannon K, Goetz C, Pilgrim D, Evans D: Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 334:71-76, 1996.
12. Bergland R: Neurosurgery may die. N Engl J Med 288:1043-1046,1973.
13. Björklund A, Stenevi U: Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res 177:555-560,1979.
14. Björklund A, Stenevi U, Dunnett SB, Gage FH: Cross-species neural grafting in a rat model of Parkinson's disease. Nature 298:652-654, 1982.
15. Blomer U, Naldini L, Verma I, Trono D, Gage F: Applications of gene therapy to the CNS. Hum Mol Genet 5:1397-1404, 1996.
16. Borlongan CV, Koutouzis T, Jorden J, Martinez R, Rodriguez A, Poulos S, Freeman T, Mckeown P, Cahill D, Nishino H, Sanberg PR: Neural transplantation as an experimental treatment modality for cerebral ischemia. Neurosci Biobehav Rev 21:79-90,1997.
17. Borlongan CV, Tajima Y, Trojanowski J, Lee V, Sanberg P: Transplanted human embryonal carcinoma-derived neurons (NT2N cells) promote functional recovery in ischémie rats. Exp Neurol 149:310-321, 1998.
18. Breeze RE, Wells T, Freed C: Implantation of fetal tissue for the management of Parkinson's disease: A technical note. Neurosurgery 36:1044-1047,1995.
19. Bregman BS, McAtee M, Dai H, Kühn PL: Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat. Exp Neurol 148:475-494, 1997.
20. Brooks B: Clinical epidemiology of amyotrophic lateral sclerosis. Neurol Clin 14:399-411, 1996.
21. Brundin P, Isacson O, Gage F, Stenevi U, Björkland A: Intracerebral grafts of neuronal cell suspensions, in Björklund A, Stenevi U (eds): Neuronal Grafting in the Mammalian CNS. Amsterdam, Elsevier, 1985, pp 51-59.
22. Cavicchioli L, Flanigan T, Dickson J, Vantini G, Toso R, Fusco M, Walsh F, Léon A: Choline acetyltransferase messenger RNA expression in developing and adult rat brain: Regulation by nerve growth factor. Brain Res Mol Brain Res 9:319-325, 1991.
23. Choi-Lundberg DL, Qing L, Yung-Nien C, Chiang Y, Hay C, Mohajeri H, Beverly L, Bohn M: Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275: 838-841,1997.
24. Collier TJ, Redmond R, Sladek C, Gallagher M, Roth R, Sladek J: Intracerebral grafting and culture of cryopreserved primate dopamine neurons. Brain Res 436:363-367, 1987.
25. Dinsmore J, Ratliff J, Deacon T, Pakzaban P, Jacoby D, Galpem W, Isacson O: Embryonic stem cells differentiated in vitro as a novel source of cells for transplantation. Cell Transplant 5:131-143, 1996.
26. Duncan ID, Grever W, Zhang S: Repair of myelin disease: Strategies and progress in animal models. Mol Med Today 3:554-561, 1997.
27. Dymecki J, Poltorak M, Freed VV: The degree of genetic disparity between donor and host correlates with survival of intraventricular substantia nigra grafts. Reg Immunol 3:17-22, 1990.
28. Elsayed MH, Hogan T, Shaw P, Castro A: Use of fetal cortical grafts in hypoxic-ischemic brain injury in neonatal rats. Exp Neurol 137:127-141, 1996.
29. Emerich DF, Winn S, Hantraye P, Pechanski M, Chen E, Chu Y, McDermott P, Baetge E, Kordower J: Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature 386:395-399, 1997.
30. Espinosa de los Monteras A, Zhao P, Huang C, Pan T, Chang R, Nazarian R, Espejo D, de Vellis J: Transplantation of CG4 oligodendrocyte progenitor cells in the myelin-deficient rat brain results in myelination of axons and enhanced oligodendroglial markers. J Neurosci Res 50:872-887, 1997.
31. Fiandaca MS, Bakay R, Sweeney K, Chan W: Immunologie response to intracerebral fetal neural allografts in the rhesus monkey. Prog Brain Res 78:287-296, 1988.
32. Fink DJ, DeLuca N, Coins WF, Glorioso JC: Gene transfer to neurons using herpes simplex virus-based vectors. Annu Rev Neurosci 19:265-287,1996.
33. Freed VVJ, Poltorak M: Comments on brain tissue transplantation without immunosuppression. Arch Neurol 48:259-262, 1991.
34. Freed CR, Breeze R, Rosenberg N, Schneck S, Kriek E, Qi J, Lone T, Zhang YB, Snyder JA, Wells TH, Ramig LO, Thompson ST, Brooks D, Sawle G, Schrotter G, Ansari AA: Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 327:1549-1555, 1992.
35. Freed CR, Breeze RE, Rosenberg NL, Schneck SA, Wells TH, Barre JN, Grafton ST, Mazziotta JC, Eidelberg D, Rottenberg DA: Therapeutic effects of human fetal dopamine cells transplanted in a patient with Parkinson's disease. Prog Brain Res 82:715-721, 1990.
36. Freed CR, Rosenberg NL, Schneck S, Breeze R: Improved drug responsiveness following fetal tissue implant for Parkinson's disease. Neurochem Int 20[Suppl]:321S-327S, 1992.
37. Freeman TB, Olanow CW, Hauser RA, Nauert GM, Smith DA, Borlongan CV, Sanberg PR, Holt DA, Kordower JH, Vingerhoets FJ, Snow BJ, Calne D, Gauger LL: Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol 38:379-388, 1995.
38. Giovanini MA, Reier P, Eskin T, Wirth E, Anderson D: Characteristics of human fetal spinal cord grafts in the adult rat spinal cord: Influences of lesion and grafting conditions. Exp Neurol 148:523-543, 1997.
39. Goetz CG, De Long MR, Perm RD, Bakay RA: Neurosurgical horizons in Parkinson's disease. Neurology 43:1-7, 1993.
40. Goetz CG, Olanow CW, Koller WC, Penn RD, Cahill D, Morantz R, Stebbins G, Tanner CM, Klawans HL, Shannon KM: Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. N Engl J Med 320:337-341,19S9.
41. Goetz CG, Tanner C, Perm R, Stebbins G, Gilley D, Shannon K, Klawans H, Cornelia C, Wilson R, Wilt T: Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1 year motor and psychomotor data. Neurology 40:273-276, 1990.
42. Grabowski M, Brundin P, Johansson BB: Functional integration of cortical grafts placed in brain infarcts of rats. Ann Neurol 34:362-368, 1993.
43. Grabowski M, Cristofferson RH, Brundin P, Johansson BB: Vascularization of fetal neocortical grafts implanted in brain infarcts in spontaneously hypertensive rats. Neuroscience 51:673-682, 1992.
44. Grabowski M, Johansson BB, Brundin P: Survival of fetal neocortical grafts implanted in brain infarcts of adult rats: The influence of postlesion time and age of donor tissue. Exp Neurol 127:125-136,1994.
45. Grabowski M, Nordborg C, Brundin P, Johansson BB: Middle cerebral artery occlusion in the hypertensive and normotensive rat: A study of histopathology and behaviour. J Hypertens 6:405-411, 1988.
46. Hadani M, Freeman T, Munsiff A, Young W, Flamm E: Fetal cortical cells survive in focal cerebral infarct after permanent occlusion of the middle cerebral artery in adult rats. J Neurotrauma 9:107-112, 1992.
47. Hammang JP, Emerich D, Winn S, Lee A, Lindner M, Gentile F, Dougherty E, Kordower J, Baetge E: Delivery of neurotrophic factors to the CNS using encapsulated cells: Developing treatments for neurodegenerative diseases. Cell Transplant 4[Suppl 1]:S27-S28, 1995.
48. Henderson BTH, Clough C, Hughes R, Hitchcock E, Kenny B: Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease. Arch Neurol 48:822-827, 1991.
49. Hitchcock E: Neural implants and recovery of function: Human work, in Rose FD, Johnson DA (eds): Recovery from Brain Damage: Reflections and Directions. New York, Plenum Press, 1992, pp 67-78.
50. Hitchcock E: Stereotactic neural transplantation. Stereotact Funct Neurosurg 62:120-133, 1994.
51. Hitchcock ER, Clough C, Hughes R, Henderson B, Delta A: Stereotactic implantation of fetal mesencephalon. Stereotact Funct Neurosurg 54-55:282-289, 1990.
52. Hitchcock E, Clough C, Hughes R, Kenny B: Transplantation in Parkinson's disease: Stereotactic implantation of adrenal medulla and foetal mesencephalon. Acta Neurochir Suppl (Wien) 46:48-50, 1988.
53. Hitchcock ER, Kenny B, Clough C, Hughes R, Henderson B, Delta A: Stereolaclic implantation of foelal mesencephalon (ST1M): The UK experience. Prog Brain Res 82:723-728,1990.
54. Houle JD, Das G: Freezing of embryonic neural tissue and its transplantalion in Ihe ral brain. Brain Res 192:570-574, 1980.
55. lacono RP, Tang Z, Mazziotta J, Graffon S, Hoehn M: Bilateral fetal grafts for Parkinson's disease: 22 months' results. Stereotact Funct Neurosurg 58:84-87, 1991.
56. Jiang N, Jiang C, Tang Z, Zhung F, Li SJ: Human foetal brain transplant trials in the treatment of Parkinsonism. Acta Acad Med Shanghai 14:1987.
57. Johansson BB, Grabowski M: Functional recovery after brain infarction: Plasticity and neural transplanlalion. Brain Pathol 4:85-95, 1994.
58. Katayama Y, Tsubokawa T, Koshinaga M, Miyazaki S: Temporal patlern of survival and dendrific growlh of felal hippocampal cells Iransplanled into ischémie lesions of Ihe adull rat hippocampus. Brain Res 562:352-355, 1991.
59. Katayama Y, Tsubokawa T, Koshinaga M, Takahata T: Transplantalion of cryopreserved fetal hippocampal cells into isché mie lesions in the adult ral hippocampus. Cell Transplant 3[Suppl 1]:S39-S41, 1994.
60. Kedar E, Palgi O, Golod G, Babai I, Barenholz Y: Delivery of cytokines by liposomes. J Immunother 20:180-193, 1997.
61. Keefover R: The clinical epidemiology of Alzheimer's disease. Neurol Clin 14:337-351, 1996.
62. Kleppner SR, Robinson K, Trojanowski J, Lee V: Transplanted human neurons derived from a teratocarcinoma cell line (NTera-2) mature, integrate, and survive for over 1 year in Ihe nude mouse brain. J Comp Neurol 357:618-632, 1995.
63. Koide K, Hashitani T, Aihara N, Mabe H, Nishino H: Improvement of passive avoidance task after grafting of fetal striatal cell suspensions in ischémie striatum in the rat. Restoralive Neurol Neurosci 5:205-214, 1993.
64. Koizumi J, Yoshida Y, Nakazawa T, Ooneda G: Experimental studies of ischémie brain edema: A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischémie rats. Jpn J Stroke 8:1-8, 1986. 64a. Kondziolka D, Wechsler L, Meltzer C, Thulborn K, Jannetta P, Slagel C, Goldstein S, Rakela J,
65. Elder E: Phase I safety and effectiveness trial of the cerebral transplantation of LBS neurons in patients with substantial fixed motor deficit following cerebral infarction. J Neurosurg 90:435A, 1999 (abstr).
66. Kopyov OV, Jacques S, Lieberman A, Duma CM, Eagle KS: Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp Neurol 149:97-108, 1998.
67. Ladner CJ, Lee J: Pharmacological drug treatment of Alzheimer disease: The cholinergic hypothesis revisited. J Neuropathol Exp Neurol 57:719-731, 1998.
68. Lindvall O, Rehncrona S, Brundin P, Gustavii B, Astedt B, Widner H, Lindholm T, Björklund A, Leenders KL, Rothwell JC: Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease: A detailed account of methodology and a 6-month follow-up. Arch Neurol 46:615-631,1989.
69. Linn F, Rinkel G, Algra A, van Gijn J: Incidence of subarachnoid hemorrhage: Role of region, year, and rate of computed tomography-A meta-analysis. Stroke 27:625-629, 1996.
70. Madrazo I, Franco-Bourland RE, Castrejon H, Cuevas C, OstroskySolis F: Fetal striatal homotransplantation for Huntington's disease: First two case reports. Neurol Res 17:312-315,1995.
71. Madrazo I, Leon V, Torres C, Aguilera MC, Varela G, Alvarez F, Fraga A, Drucker-Colin R, Ostrosky F, Skurovich M, Franco R: Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease. N Engl J Med 318:51, 1988 (letter).
72. Mampalam TJ, Gonzalez M, Weinstein P, Sharp F: Neuronal changes in fetal cortex transplanted to ischémie adult cortex. J Neurosurg 69:904-912, 1988.
73. Mantione JR, Kleppner S, Miyazono M, Wertkin A, Lee V, Trojanowski J: Human neurons that constitutively secrete AB do not induce Alzheimer's disease pathology following transplantation and long-term survival in the rodent brain. Brain Res 671:333-337, 1995.
74. Medtronic, Inc.: Annual Report and Overview. Minneapolis, Medtronic, Inc., 1998.
75. Mocchetti I, Wrathall J: Neurotrophic factors in central nervous system trauma. J Neurotrauma 12:853-871,1995.
76. Molina H, Quinones R, Lazaro A, Galarraga J, Piedra J, Suarez C, Rachid M, Garcia JC, Perry TL, Santan A, Carmanale H, Macias R, Torres O, Rojas MJ, Federico C, Munoz JL: Transplantation of human fetal mesencephalic tissue in caudate nucleus as treatment for Parkinson's disease: The Cuban experience, in Lindvall O, Björklund A, Widner H (eds): Intracerebral Transplantation in Movement Disorders: Experimental Basis and Clinical Experiences. Amsterdam, Elsevier Science, 1991, pp 99-110.
77. Mudick LA, Leung P, Baimbridge K, Miller J: Neuronal transplants used in the repair of acute ischémie injury in the central nervous system. Prog Brain Res 78:87-93, 1988.
78. Nishino H, Aihara N, Czurko A, Hashitani T, Isobe Y, Ichikawa O, Watari H: Reconstruction of GABAergic transmission and behavior by striatal cell grafts in rats with ischémie infarcts in the middle cerebral artery. J Neural Transplant Plast 4:147-155, 1993.
79. Nunn J, Hodges H: Cognitive deficits induced by global cerebral ischaemia: Relationship to brain damage and reversal by transplants. Behav Brain Res 65:1-31, 1994.
80. Olanow CW, Kordower ], Freeman T: Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci 19: 102-109, 1996.
81. Onifer SM, Low W: Spatial memory deficit resulting from ischemia-induced damage to the hippocampus is ameliorated by intra-hippocampal transplants of fetal hippocampal neurons. Prog Brain Res 82:359-366,1990.
82. Onizuka K, Fukuda A, Kunimatsu M, Kumazaki M, Sasaki M, Takaku A, Nishino H: Early cytopathic features in rat ischemia model and reconstruction by neural graft. Exp Neurol 137:324-332,1996.
83. Perm R: The future of CNS infusion systems, in Gildenberg PL, Tasker RR, Franklin OP (eds): Textbook of Stereotadic and Functional Neurosurgery. New York, McGraw-Hill, 1998, pp 2073-2076.
84. Perm RD, Kroin JS, York MM, Cedarbaum JM: Intrathecal ciliary neurotrophic factor delivery for treatment of amyotrophic lateral sclerosis (Phase I trial). Neurosurgery 40:94-100, 1997.
85. Pincus DW, Goodman R, Fräser R, Nedergaard M, Goldman S: Neural stem and progenitor cells: A strategy for gene therapy and brain repair. Neurosurgery 42:858-868, 1998.
86. Pizzorusso T, Porciatti V, Tseng J, Aebischer P, Maffei L: Transplant of polymer-encapsulated cells genetically engineered to release nerve growth factor allows a normal functional development of the visual cortex in dark-reared cats. Neuroscience 80:307-311, 1997.
87. Pleasure SJ, Lee V: NTera 2 cells: A human cell line which displays characteristics expected of a human committed progenitor cell. J Neurosci Res 35:585-602, 1993.
88. Preston-Martin S: Epidemiology of primary CNS neoplasms. Neurol Clin 14:273-290, 1996.
89. Sabate O, Horellou P, Vigne E, Colin P, Perricaudet M, BucCaron M, Mallet J: Transplantation to the rat brain of human neural progenitors that were genetically modified using adenoviruses. Nat Genet 9:256-260, 1995.
90. Schumacher JM, Palmer P, Ellias S, Fink S, Isacson O: Transplantation of fetal pig cells for Parkinson's disease: Preliminary results. Presented at the American Association of Neurological Surgeons Conference, Philadelphia, April 1998.
91. Scolding N: Strategies for repair and remyelination in demyelinating diseases. Curr Opin Neurol 10:193-200, 1997.
92. Sedgwick JD, Schwender S, Gregersen R, Domes R, Meulen VT: Resident macrophages (ramified microglia) of the adult brown Norway rat central nervous system are constitutively major histocompatibility complex class U positive. J Exp Med 177:1145-1152,1993.
93. Shannon KM, Kordower J: Neural transplantation for Huntington's disease: Experimental rationale and recommendations for clinical trials. Cell Transplant 5:339-352, 1996.
94. Sharp F: Transplants for stroke? Ann Neurol 34:322-323,1993.
95. Sladek JR Jr, Collier TJ, Haber SN, Roth RH, Redmond DE Jr: Survival and growth of fetal catecholamine neurons transplanted into primate brain. Brain Res Bull 17:809-818, 1986.
96. Sladek JR Jr, Redmond DE Jr, Collier TJ, Blount JP, Elsworth JD, Taylor JR, Roth RH: Fetal dopamine neural grafts: Extended reversal of methylphenyltetrahydropyridine-induced parkinsonism in monkeys. Prog Brain Res 78:497-506, 1988.
97. Spencer DD, Robbins RJ, Naftolin F, Marek K, Vollmer T, Leranth C, Roth RH, Price LH, Gjedde A, Bunney BS, Sass KJ, Elsworth JD, Kier L, Makuch R, Hoffer PB, Redmond DE Jr: Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med 327:1541-1548,1992.
98. Tamura A, Graham D, McCulloch J, Teasdale G: Focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 1:53-60, 1981.
99. Tanner CM, Goldman S: Epidemiology of Parkinson's disease. Neurol Clin 14:317-332,1996.
100. Targett MP, Sussman J, Scolding N, O'Leary M, Compston D, Blakemore W: Failure to achieve remyelination of demyelinated rat axons following transplantation of glial cells obtained from the adult human brain. Neuropathol Appl Neurobiol 22:199-206, 1996.
101. 99a. Thompson WG: Successful brain grafting. N Y Med J 51:701-702, 1890.
102. Thompson DW, Furlan A: Clinical epidemiology of stroke. Neurosurg Clin N Am 8:265-269, 1997.
103. Trojanowski JQ, Mantione J, Lee J, Seid D, You T, Inge L, Lee V: Neurons derived from a human teratocarcinoma cell line establish molecular and structural polarity following transplantation into rodent brain. Exp Neurol 122:283-294,1993.
104. Vonsattiel JPG, DiFiglia M: Huntington disease. J Neuropathol Exp Neurol 57:369-384, 1998.
105. Walker AE, Robins M, Weinfeld F: Epidemiology of brain tumors: The national survey of intracranial neoplasms. Neurology 35:219-226,1985.
106. Weinshenker B: Epidemiology of multiple sclerosis. Neurol Clin 14:291-308, 1996.
107. Wekerle H, Linnington C, Lassmann H, Meyermann R: Cellular immune reactivity within the CNS. Trends Neurosci 9:271-277, 1986.
108. White RJ, Albin M, Yashon D: Neuropathological investigation of the transplanted canine brain. Transplant Proc 1:259-261, 1969.
109. Whittemore SR, Snyder E: Physiological relevance and functional potential of central nervous system-derived cell lines. Mol Neurobiol 12:13-38, 1996.
110. Winn SR, Lindner M, Lee A, Haggett G, Francis ], Emerich D: Polymer-encapsulated genetically modified cells continue to secrete human nerve growth factor for over one year in rat ventricles: Behavioral and anatomical consequences. Exp Neurol 140:126-138, 1996.
111. Wolff JA, Fisher L, Xu L, Jinnah H, Langlias P, luvone P, O'Malley K, Rosenberg MB, Shimohama S, Friedmann T, Gage FH: Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson's disease. Proc Natl Acad Sei USA 86:9011-9014, 1989.
112. Wood MJA, Sloan D, Dallman M, Charlton H: Specific tolerance to neural allografts induced with an antibody to the interleukin 2 receptor. J Exp Mcd 177:597-603, 1993.
113. Yang K, Clifton G, Hayes R: Gene therapy for central nervous system injury: The use of cationic liposomes-An invited review. J Neurotrauma 14:281-291, 1997.
114. Young B, Patchell R: Brain métastases, in Youmans JR (ed): Neurological Surgery. Philadelphia, W.B. Saunders Co., 1996, ed 4, vol 4, pp 2748-2749.
115. Yuen EC, Mobley W: Therapeutic potential of neurotrophic factors for neurological disorders. Ann Neurol 40:347-354, 1996.
116. Zlokovic BV, Apuzzo MLJ: Cellular and molecular neurosurgery: Pathways from concept to reality-Part I: Target disorders and concept approaches to gene therapy of the central nervous system. Neurosurgery 40:789-804, 1997.
117. Zlokovic BV, Apuzzo MLJ: Cellular and molecular neurosurgery: Pathways from concept to reality-Part II: Vector systems and delivery methodologies for gene therapy of the central nervous system. Neurosurgery 40:805-813, 1997.
118. Zompa EA, Cain L, Everhart A, Moyer M, Hulsebosch C: Transplant therapy: Recovery of function after spinal cord injury. J Neurotrauma 14:479-500, 1997.